Company Filing History:
Years Active: 2023-2024
Title: Thomas Courtney Gardinier, II: Innovator in Nanoparticle Drug Conjugates
Introduction
Thomas Courtney Gardinier, II is a notable inventor based in Raritan, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative work in nanoparticle drug conjugates. With a total of 2 patents, Gardinier is recognized for his advancements in targeted drug delivery systems.
Latest Patents
Gardinier's latest patents include "Folate receptor targeted nanoparticle drug conjugates and uses thereof." This disclosure relates to nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates. The methods outlined in these patents focus on making and using these conjugates to treat cancer effectively.
Career Highlights
Gardinier is currently associated with Elucida Oncology, Inc., where he continues to develop innovative solutions for cancer treatment. His work emphasizes the importance of targeted therapies in improving patient outcomes.
Collaborations
Some of his notable coworkers include Kai Ma and Aranapakam Mudumbai Venkatesan. Their collaborative efforts contribute to the advancement of research and development in the field of oncology.
Conclusion
Thomas Courtney Gardinier, II is a prominent figure in the realm of nanoparticle drug conjugates, with a focus on cancer treatment. His innovative patents and work at Elucida Oncology, Inc. highlight his commitment to improving therapeutic strategies for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.